We have recently demonstrated that under basal conditions, 5-HT7R physically interacts with CDK5, which results in kinase activation leading to pathological Tau aggregation, impaired LTP, and cognitive deficits in mice [14, 36]. The gene discussed is CDK5; the disease is Cognitive impairment.